Protocols
1 protocol(s) meet the specified criteria
Drug: mFOLFOX-6
Protocol No.TitleStatus
GO30140An Open-Label, Multicenter Phase Ib Study of the Safety and Tolerability of Atezolizumab (ANTI-PD L1 Antibody) Administered in combination with Bevacizumab and/or other Treatments in Patients with Solid Tumors.Open